newsfilter
← Latest News
Business Wire·

VBI Vaccines Announces Poster Presentation at EASL 2023

VBI Vaccines Inc. (NASDAQ:VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that an abstract highlighting T-cell responses and